Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2009
10/22/2009US20090263401 USES OF IL-174 ANTAGONISTS FOR INHIBITING A Th2 IMMUNE RESPONSE
10/22/2009US20090263395 Genes and polypeptides relating to breast cancers
10/22/2009US20090263389 Use of TGF-Beta Antagonists to Treat or to Prevent Chronic Transplant Rejection
10/22/2009US20090263388 Methods of preventing or treating cardiovascular, cerebrovascular and thrombotic disorders with tumor necrosis factor antagonists
10/22/2009US20090263377 Il-32b-targeted diagnosis and therapy
10/22/2009US20090263374 Method of preventing and treating brain infarction
10/22/2009US20090263373 Non-neurotoxic plasminogen activating factors for treating of stroke
10/22/2009US20090263372 Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same
10/22/2009US20090263371 Use Polysaccharides for Promotion of Enzymatic Activity
10/22/2009US20090263370 Methods for treating tachykinin-mediated diseases with cholinesterase
10/22/2009US20090263369 Using anabaena variabilis ammonia lyase variant as therapeutic in treatment of cell proliferative disorders; antitumor agents
10/22/2009US20090263368 Genetic variations associated with psychiatric disorders
10/22/2009US20090263367 Composition and method for promoting internal health and external appearance
10/22/2009US20090263363 Compositions and Methods For Treating Bone Formation Disorders
10/22/2009US20090263362 Fertility enhancement using lipid carriers and bioactive molecules
10/22/2009US20090263355 Deamidated interferon-beta
10/22/2009US20090263354 Compositions and siRNAs for inhibiting C/EBPbeta
10/22/2009US20090263353 Novel Sulphonylpyrroles as Inhibitors of Hdac S Novel Sulphonylpyrroles
10/22/2009US20090263352 Methods for treating viral infection using il-28 and il-29 cysteine mutants
10/22/2009US20090263351 Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases
10/22/2009US20090263350 Cosmetic and dermatological methods
10/22/2009US20090263349 Methods and compositions for inhibiting angiogenesis
10/22/2009US20090263348 Nucleic Acids Encoding Multimeric Fusion Proteins of TNF Superfamily Ligands
10/22/2009US20090263335 Use of aerosolized cyclosporine for prevention and treatment of pulmonary disease
10/22/2009US20090263334 Cyclic Glycyl-2-Allyl Proline Improves Cognitive Performance in Impaired Animals
10/22/2009US20090263323 Novel means and methods for the treatment of hearing loss and phantom hearing
10/22/2009US20090263320 Peptide-Based Compounds
10/22/2009US20090262219 Digital Camera
10/22/2009CA2758415A1 Plectin-1 targeted agents for detection and treatment of pancreatic ductal adenocarcinoma
10/22/2009CA2725257A1 Recombinant fsh including alpha 2,3- and alpha 2,6-sialylation
10/22/2009CA2722308A1 Nucleoside derivatives for treatment of caliciviridae infections, including norovirus infections
10/22/2009CA2721635A1 Compositions comprising halorhodopsin
10/22/2009CA2721507A1 Methods of generating and using procollagen
10/22/2009CA2721506A1 Compositions and methods for treating or preventing prostate cancer and for detecting androgen receptor variants
10/22/2009CA2721453A1 Sparc anti-inflammatory activity and uses thereof
10/22/2009CA2721341A1 Ameliorating agent for neurogenic pain
10/22/2009CA2721335A1 Process for preparing bioabsorbable sheet preparation holding thrombin
10/22/2009CA2721229A1 Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions
10/22/2009CA2721156A1 Stable amyloid beta monomers and oligomers
10/22/2009CA2720980A1 Methods for enhanced production of bone morphogenetic proteins
10/22/2009CA2720845A1 Liquid buffered gdf-5 formulations
10/22/2009CA2720203A1 Osteogenic composition including a complex growth factor/amphiphilic polymer, a soluble cation salt, and an organic substrate
10/22/2009CA2693001A1 Compositions and methods for treating pathologic angiogenesis and vascular permeability
10/21/2009EP2110669A1 Methods for the identification of allo-antigens and their use for cancer therapy and transplantation
10/21/2009EP2110436A1 Polypeptides having neutrophil stimulating activity
10/21/2009EP2110434A1 Type-1 cytokine receptor GLM-R
10/21/2009EP2110431A1 Cartilage regeneration using human mesenchymal stem cells
10/21/2009EP2110385A1 Stabilized factor VIII with engineered disulfide bonds
10/21/2009EP2110384A1 Hepatopoietin and use thereof
10/21/2009EP2110381A1 Long lasting fusion peptide inhibitors of viral infection
10/21/2009EP2110379A2 Mammalian sphingosine kinase type 2 isoforms, and uses thereof
10/21/2009EP2110142A2 Inhibition of secretion from non-neuronal cells
10/21/2009EP2110138A1 Dosages for treatment of anti-erbB2 antibodies
10/21/2009EP2110136A2 Pharmaceutical composition for treating haemorrhagic shock and its consecutive symptoms
10/21/2009EP2109682A2 Enhanced cell-free synthesis of active proteins containing disulfide bonds
10/21/2009EP2109619A2 Modifications of peptide compositions to increase stability and delivery efficiency
10/21/2009EP2109457A1 Therapeutic application of kazal-type serine protease inhibitors
10/21/2009EP2109456A2 Human epo receptor agonists, compositions, methods and uses for preventing or treating glucose intolerance related conditions
10/21/2009EP2109455A2 Compositions and methods for stimulating an immune response
10/21/2009EP2109454A1 Glp-1 pharmaceutical compositions
10/21/2009EP2109440A2 Association of compounds inhibiting melanogenesis and use thereof in cosmetics and dermatology
10/21/2009EP2024387B1 Peptide substance enhancing capillaries resistance, pharmaceutical composition on its base and method of its application
10/21/2009EP1981903B1 Asparagine-10-substituted nonadepsipeptides
10/21/2009EP1776138B1 tRNA SYNTHETASE FRAGMENTS
10/21/2009EP1761553B1 Tumor-associated peptides that bind to mhc-molecules
10/21/2009EP1716176B1 Cd38 splice variant and uses thereof
10/21/2009EP1654378B1 Methods for chemically synthesizing immunoglobulin chimeric proteins
10/21/2009EP1501465B1 Vectors having both isoforms of beta-hexosaminidase
10/21/2009EP1429623B1 Delivery of disease control in aquaculture and agriculture using nutritional feeds containing bioactive proteins produced by viruses
10/21/2009EP1423413B1 Peptidic compounds selectively binding to p-selectin
10/21/2009EP1415154B1 Control of growth and repair of gastro-intestinal tissues by gastrokines
10/21/2009EP1407276B1 Use of hypoxia inducible factor 2alpha for curing neonatal respiratory distress syndrome
10/21/2009EP1397386B1 Chimeric proteins for cell targeting and apoptosis induction and methods of using the same
10/21/2009EP1383778B1 Agonists and antagonists of sphingosine-1-phosphate receptors
10/21/2009EP1371373B1 Recombination super compound interferon used as hepatitis b surface antigen and e antigen inhibitor
10/21/2009EP1207877B1 Anti-inflammatory actions of cytochrome p450 epoxygenase-derived eicosanoids
10/21/2009EP1109576B1 Immunogenic beta-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an n-acryloylated polysaccharide
10/21/2009EP1047784B1 Neissera meningitidis antigens
10/21/2009EP0959899B9 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION
10/21/2009CN101563364A Insulinotropic peptide synthesis
10/21/2009CN101563362A Recombinant HCV E2 glycoprotein
10/21/2009CN101563360A Peptide-cytotoxic conjugates
10/21/2009CN101563134A Method and pharmacological composition for the diagnosis and treatment of male sub-fertility
10/21/2009CN101563103A Novel nematode protein and its use in producing anthelminthic agents and vaccines
10/21/2009CN101563102A Method of treating endothelial dysfunction
10/21/2009CN101563101A Methods and compositions for stabilizing prostate specific antigen
10/21/2009CN101563100A Novel drug target of preventing and treating periodontal disease, improving healing of periodontal wounds and promoting oral health
10/21/2009CN101563099A Use of beta-lactamase
10/21/2009CN101563098A IL-17A/F heterologous polypeptides and therapeutic uses thereof
10/21/2009CN101563097A Stem cell factor therapy for tissue injury
10/21/2009CN101563096A Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus
10/21/2009CN101563078A Improved biological effects of compositions comprising rosmarinic acid
10/21/2009CN101560546A Application of Phosphatidylinositol4-kinase type II alpha PI4KIIalpha
10/21/2009CN101560510A Agkistrodon acutus hemocoagulase atrox
10/21/2009CN101560501A Recombinant adenovirus capable of selectively expressing FADD, construction method and application thereof
10/21/2009CN101560478A Bacillus subtilis subso natto for producing natto kinase and application thereof
10/21/2009CN101560253A Method for the crystallization of human serum albumin
10/21/2009CN101560246A Thymopentin derivate, preparation method and application of derivate and compound containing derivate in preparing drugs
10/21/2009CN101560243A Method for separating and purifying abrin and product thereof
10/21/2009CN101559219A Preparation for phimosis, andrological inflammation and sexual disorder and production method thereof
1 ... 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 ... 3163